Lymphocyte function in anergic patients

H. N. Rode, N. V. Christou, O. Bubenik, R. Superina, J. Gordon, J. L. Meakins, L. D. MacLean

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The lymphocyte function of anergic surgical patients who are at increased risk for sepsis and mortality was studied. In vitro lymphocyte responses appear to be normal in most instances, in that over 80% of patients showed a normal response in a standardized mixed leucocyte culture reaction. Similarly, 56% of the lymphocytes from anergic patients showed a positive in vitro proliferative response with PPD. The ability of in vitro-activated lymphocytes to elicit a skin reaction was determined by culturing the cells of anergic patients with PPD and then reinjecting the lymphocytes or their supernatants intradermally into the original donor. When there was a positive proliferative response to PPD in vitro, the reinjected cells or supernatant elicited a positive skin reaction in 79% of the anergic patients. In contrast, a skin reaction was obtained in less than 20% of the instances when there was no in vitro proliferation to PPD or when the cells were cultured without antigen. These results suggest that one of the acquired immune defects in these anergic patients is an in vivo block of lymphocyte activation.

Original languageEnglish (US)
Pages (from-to)155-161
Number of pages7
JournalClinical and Experimental Immunology
Volume47
Issue number1
StatePublished - Feb 6 1982

Fingerprint

Tuberculin
Lymphocytes
Skin
Mixed Lymphocyte Culture Test
Lymphocyte Activation
Cultured Cells
Sepsis
In Vitro Techniques
Tissue Donors
Antigens
Mortality

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Rode, H. N., Christou, N. V., Bubenik, O., Superina, R., Gordon, J., Meakins, J. L., & MacLean, L. D. (1982). Lymphocyte function in anergic patients. Clinical and Experimental Immunology, 47(1), 155-161.
Rode, H. N. ; Christou, N. V. ; Bubenik, O. ; Superina, R. ; Gordon, J. ; Meakins, J. L. ; MacLean, L. D. / Lymphocyte function in anergic patients. In: Clinical and Experimental Immunology. 1982 ; Vol. 47, No. 1. pp. 155-161.
@article{2279d85e3deb46ecbf16fbb5d0acf2cc,
title = "Lymphocyte function in anergic patients",
abstract = "The lymphocyte function of anergic surgical patients who are at increased risk for sepsis and mortality was studied. In vitro lymphocyte responses appear to be normal in most instances, in that over 80{\%} of patients showed a normal response in a standardized mixed leucocyte culture reaction. Similarly, 56{\%} of the lymphocytes from anergic patients showed a positive in vitro proliferative response with PPD. The ability of in vitro-activated lymphocytes to elicit a skin reaction was determined by culturing the cells of anergic patients with PPD and then reinjecting the lymphocytes or their supernatants intradermally into the original donor. When there was a positive proliferative response to PPD in vitro, the reinjected cells or supernatant elicited a positive skin reaction in 79{\%} of the anergic patients. In contrast, a skin reaction was obtained in less than 20{\%} of the instances when there was no in vitro proliferation to PPD or when the cells were cultured without antigen. These results suggest that one of the acquired immune defects in these anergic patients is an in vivo block of lymphocyte activation.",
author = "Rode, {H. N.} and Christou, {N. V.} and O. Bubenik and R. Superina and J. Gordon and Meakins, {J. L.} and MacLean, {L. D.}",
year = "1982",
month = "2",
day = "6",
language = "English (US)",
volume = "47",
pages = "155--161",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "1",

}

Rode, HN, Christou, NV, Bubenik, O, Superina, R, Gordon, J, Meakins, JL & MacLean, LD 1982, 'Lymphocyte function in anergic patients', Clinical and Experimental Immunology, vol. 47, no. 1, pp. 155-161.

Lymphocyte function in anergic patients. / Rode, H. N.; Christou, N. V.; Bubenik, O.; Superina, R.; Gordon, J.; Meakins, J. L.; MacLean, L. D.

In: Clinical and Experimental Immunology, Vol. 47, No. 1, 06.02.1982, p. 155-161.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lymphocyte function in anergic patients

AU - Rode, H. N.

AU - Christou, N. V.

AU - Bubenik, O.

AU - Superina, R.

AU - Gordon, J.

AU - Meakins, J. L.

AU - MacLean, L. D.

PY - 1982/2/6

Y1 - 1982/2/6

N2 - The lymphocyte function of anergic surgical patients who are at increased risk for sepsis and mortality was studied. In vitro lymphocyte responses appear to be normal in most instances, in that over 80% of patients showed a normal response in a standardized mixed leucocyte culture reaction. Similarly, 56% of the lymphocytes from anergic patients showed a positive in vitro proliferative response with PPD. The ability of in vitro-activated lymphocytes to elicit a skin reaction was determined by culturing the cells of anergic patients with PPD and then reinjecting the lymphocytes or their supernatants intradermally into the original donor. When there was a positive proliferative response to PPD in vitro, the reinjected cells or supernatant elicited a positive skin reaction in 79% of the anergic patients. In contrast, a skin reaction was obtained in less than 20% of the instances when there was no in vitro proliferation to PPD or when the cells were cultured without antigen. These results suggest that one of the acquired immune defects in these anergic patients is an in vivo block of lymphocyte activation.

AB - The lymphocyte function of anergic surgical patients who are at increased risk for sepsis and mortality was studied. In vitro lymphocyte responses appear to be normal in most instances, in that over 80% of patients showed a normal response in a standardized mixed leucocyte culture reaction. Similarly, 56% of the lymphocytes from anergic patients showed a positive in vitro proliferative response with PPD. The ability of in vitro-activated lymphocytes to elicit a skin reaction was determined by culturing the cells of anergic patients with PPD and then reinjecting the lymphocytes or their supernatants intradermally into the original donor. When there was a positive proliferative response to PPD in vitro, the reinjected cells or supernatant elicited a positive skin reaction in 79% of the anergic patients. In contrast, a skin reaction was obtained in less than 20% of the instances when there was no in vitro proliferation to PPD or when the cells were cultured without antigen. These results suggest that one of the acquired immune defects in these anergic patients is an in vivo block of lymphocyte activation.

UR - http://www.scopus.com/inward/record.url?scp=0020077112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020077112&partnerID=8YFLogxK

M3 - Article

C2 - 6212172

AN - SCOPUS:0020077112

VL - 47

SP - 155

EP - 161

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 1

ER -

Rode HN, Christou NV, Bubenik O, Superina R, Gordon J, Meakins JL et al. Lymphocyte function in anergic patients. Clinical and Experimental Immunology. 1982 Feb 6;47(1):155-161.